Page last updated: 2024-10-24

chlorambucil and Peritoneal Neoplasms

chlorambucil has been researched along with Peritoneal Neoplasms in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Móller, TR1
Brandt, L1
Kónyves, I1
Lindberg, G1
Nogales, FF1
Oliva, HA1

Other Studies

2 other studies available for chlorambucil and Peritoneal Neoplasms

ArticleYear
Therapeutic effect of Leo 1031, an alkylating corticosteroid ester; in lymphoproliferative disorders. II. Lymphocytic lymphoma.
    Acta medica Scandinavica, 1975, Volume: 197, Issue:4

    Topics: Adult; Aged; Bone Marrow; Chlorambucil; Drug Evaluation; Drug Therapy, Combination; Esters; Female;

1975
Peritoneal gliomatosis produced by ovarian teratomas.
    Obstetrics and gynecology, 1974, Volume: 43, Issue:6

    Topics: Adult; Chlorambucil; Dactinomycin; Fallopian Tubes; Female; Glioma; Humans; Hysterectomy; Methotrexa

1974